DOTting the path to doom: how acceleration of histone methylation leads to leukemia

Christian Bach1, Robert K Slany2

  • 1Department of Internal Medicine 5, Hematology/Oncology, University of Erlangen-Nuremberg, 91054 Erlangen, Germany.

Cancer Cell
|December 10, 2014
PubMed

Epigenetic control mechanisms are central to normal and malignant hematopoiesis. In this issue of Cancer Cell, Deshpande and colleagues demonstrate that AF10, an interaction partner of the histone methyltransferase DOT1L, is essential for efficient H3K79 methylation, thus regulating HOX-gene transcription and transformation in myeloid leukemia.